A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells()()

The therapeutic effect in non–small cell lung cancer (NSCLC) patients is limited because of intrinsic and acquired resistance. Thus, an unmet need exists for the development of new drugs to improve the therapeutic efficacy in NSCLC patients. In this study, the novel small molecule indolizino[6,7-b]i...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neoplasia
मुख्य लेखकों: Chen, Chi-Wei, Wu, Ming-Hsi, Chen, Yi-Fan, Yen, Tsai-Yi, Lin, Yi-Wen, Chao, Shu-Hsin, Tala, Satishkumar, Tsai, Tung-Hu, Su, Tsann-Long, Lee, Te-Chang
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Neoplasia Press 2016
विषय:
Original article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840272/
https://ncbi.nlm.nih.gov/pubmed/27108383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.02.005
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन